Reuters: Senator has questions on Amgen anemia drug rebates

[counter]

Senator has questions on Amgen anemia drug rebates
      

WASHINGTON (Reuters) - U.S. Sen. Charles Grassley asked Amgen Inc to explain why some physician groups received higher rebates for purchasing the company's anti-anemia drug Aranesp, a letter released on Thursday said.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login